Nature Medicine
3, 593 (1997)
doi:10.1038/nm0697-593
p27 expression and gastric carcinomaMasaki Mori1, Koshi Mimori1, Takeshi Shiraishi1, Shinji Tanaka1, Hiroaki Ueo2, Keizo Sugimachi3
& Tsuyoshi Akiyoshi1
1Department of Surgery, Medical Institute of Bioregulation, Kyushu University, Beppu 874, Japan
2Department of Surgery, Oita Prefectural Hospital, Oita 875 Japan
3Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka 812, Japan
REFERENCES
- Porter, P.L. et al. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222−225 (1997). | Article | PubMed | ISI | ChemPort |
- Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med. 3, 231−234 (1997). | Article | PubMed | ISI | ChemPort |
- Catzavelos, C. et al. Decreased levels of the cell-cycle inhibitor p27Klpl protein: Prognostic implications in primary breast cancer. Nature Med. 3, 227−230 (1997). | Article | PubMed | ISI | ChemPort |
- Steeg, P.S. & Abrams, J.S. Cancer prognostics: Past, present and p27. Nature Med. 3, 152−154 (1997). | Article | PubMed | ISI | ChemPort |
|
